Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 14.2B | 16.2B | 16.1B | 16.7B |
| Cost of revenue | 9.3B | 10.7B | 10.4B | 10.5B |
| Gross profit | 5.0B | 5.6B | 5.7B | 6.2B |
| Operating expense | ||||
| Research & development | 480M | 519M | 533M | 535M |
| Selling general and admin | 1.6B | 1.8B | 1.7B | 1.7B |
| Other operating expenses | 306M | 344M | 355M | 556M |
| Operating income | 2.6B | 2.9B | 3.1B | 3.5B |
| Non operating interest income | ||||
| Income | — | 120M | 108M | 118M |
| Expense | 116M | 107M | 125M | 137M |
| Other income expense | 107M | 426M | 76M | 155M |
| Pretax income | 2.6B | 3.2B | 3.1B | 3.5B |
| Tax provision | 574M | 463M | 642M | 836M |
| Net income | 2.0B | 2.8B | 2.5B | 2.7B |
| Basic EPS | 21.1 | — | 25.5 | 27.5 |
| Diluted EPS | 21 | — | 25.3 | 27.4 |
| Basic average shares | 95.0M | — | 96.8M | 97.4M |
| Diluted average shares | 95.4M | — | 97.3M | 97.9M |
| EBITDA | 3.1B | 3.6B | 3.8B | 4.0B |
| Net income from continuing op. | 2.0B | 2.8B | 2.5B | 2.7B |
| Minority interests | 0 | 1M | 1M | 0 |
| Preferred stock dividends | — | — | — | — |